Research Interests:
1. Continuing evaluation of the pathogenesis, complications, and treatments of bacterial vaginosis.
2. Evaluation of topically applied imunomodulator therapy for condylomata acuminata, and prevention of genital HPV infection.
3. Evaluation of new preventative measures, treatments, and diagnostic tests for genital chlamydial infection.
4. Evaluation of new antibiotic agents for treatment of postoperative pelvic infections.
5. Evaluation of diagnostic and treatment modalities for pelvic inflammatory disease.
Representative Publications:
Livengood, CH III, Boggess, KA, Wrenn, JW, et al. Performance of a Commercial Polymerase Chain Reaction Test for Laboratory Diagnosis of Endocervical Chlamydia trachomatis Infection in a University Hospital Patient Population. Infect Dis Obstet Gynecol, 6:224-9, 1998.
(1998)
Livengood CH III, McGregor JA, Soper DE, Newton E, Thomason JL. Bacterial Vaginosis: Efficacy and safety of intravaginal metronidazole treatment. Am J Obstet Gynecol 1994; 270:759-64.
(1994)
Livengood CH III, Hill GB, Addison WA. Pelvic inflamatory disease: findings during inpatient treatment of clinically severe, laparoscopy-documented disease. Am J Obstet Gynecol 1992; 166-519-24
(1992)
Livengood CH, Schmitt JW, Addison, Wrenn JW, Margruder-Habib K. Direct fluuorescent antibody testing for endocervical Chlamydia trachomatis: factors affecting accuracy, Obstet Gynecol 1990; 76:118.
(1990)
Livengood CH III, Thomason JL, Hill GB. Bacterial Vaginosis: Diagnostic and pathogenetic findings during topical clindamycin therapy. Am J Obstet Gynecol 1990; 163:515.
(1990)